Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > chart

<< Previous

Bullboard Posts

Next >>

Comment by imatryinon Mar 28, 2018 7:33am

160 Views

Post# 27792635

RE:chart

These are the Nasdaq short numbers from the 1st half of March. Massive jump in shorts (close to 600%) - no surprise there. Now the company just needs to deliver some positive news to get rid of them.

https://www.wsj.com/mdc/public/page/2_3062-nasdaqshort-highlites.html

19

Neovasc Inc. - Common Shares

NVCN

4,622,910

678,494

3,944,416

581.4

5.2

0

39,583,798

<< Previous

Bullboard Posts